Our Company

Tandem Diabetes Care, Inc. is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells a family of insulin pump products, which includes the t:slim X2™ Insulin Pump, the next-generation color touchscreen pump, the t:flex® Insulin Pump, the first pump designed for people with greater insulin requirements, and the t:slim G4™ Insulin Pump, the first CGM-enabled pump with touch-screen simplicity. Tandem is based in San Diego, California.

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Tandem Diabetes Care's financial performance into perspective.

Stock Quote
NASDAQ: TNDM
Price:
$1.20
Change:
-0.35
Day High:
1.30
Day Low:
1.15
Volume:
6,267,314
1:59 PM ET on Mar 23, 2017

View all »   RSSRecent Releases

Mar 23, 2017
Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock

Mar 8, 2017
Tandem Diabetes Care Announces Filing of Registration Statement for Proposed Follow-on Public Offering of Common Stock